Pharmacogenetic and Pharmacokinetic Dose Individualization of the Taxane Chemotherapeutic Drugs Paclitaxel and Docetaxel

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|33|3559-3582

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.33, 2017-10, pp. : 3559-3582

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

By Schlatter Chantal   Egger Sabin S.   Tchambaz Lydia   Krähenbühl Stephan  

Drug Safety, Vol. 32, Iss. 7, 2009-07 ,pp. : 561-578

Adis International

Access to resources Recommend Favorite

Albumin-bound paclitaxel: a next-generation taxane

By Gradishar William J  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 1041-1053

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of Oral Anticoagulants: A Basis for Dose Individualization

By Stehle Simone  

Clinical Pharmacokinetics, Vol. 47, Iss. 9, 2008-01 ,pp. : 565-594

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity

By  

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 932-943

Bentham Science Publishers

Access to resources Recommend Favorite